Author
Listed:
- Scott R. Floyd
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Beth Israel Deaconess Medical Center)
- Michael E. Pacold
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Dana-Farber Cancer Institute
Whitehead Institute)
- Qiuying Huang
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Scott M. Clarke
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Fred C. Lam
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Ian G. Cannell
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Bryan D. Bryson
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Jonathan Rameseder
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Michael J. Lee
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Emily J. Blake
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Anna Fydrych
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Richard Ho
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Benjamin A. Greenberger
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Grace C. Chen
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Amanda Maffa
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Amanda M. Del Rosario
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- David E. Root
(Broad Institute of Harvard and MIT)
- Anne E. Carpenter
(Broad Institute of Harvard and MIT)
- William C. Hahn
(Broad Institute of Harvard and MIT
Dana-Farber Cancer Institute)
- David M. Sabatini
(Whitehead Institute
Broad Institute of Harvard and MIT)
- Clark C. Chen
(Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center)
- Forest M. White
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Massachusetts Institute of Technology)
- James E. Bradner
(Broad Institute of Harvard and MIT
Dana-Farber Cancer Institute)
- Michael B. Yaffe
(Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Broad Institute of Harvard and MIT
Beth Israel Deaconess Medical Center
Massachusetts Institute of Technology)
Abstract
Isoform B of the chromatin-binding protein Brd4 acts to suppress DNA damage response signalling.
Suggested Citation
Scott R. Floyd & Michael E. Pacold & Qiuying Huang & Scott M. Clarke & Fred C. Lam & Ian G. Cannell & Bryan D. Bryson & Jonathan Rameseder & Michael J. Lee & Emily J. Blake & Anna Fydrych & Richard Ho, 2013.
"The bromodomain protein Brd4 insulates chromatin from DNA damage signalling,"
Nature, Nature, vol. 498(7453), pages 246-250, June.
Handle:
RePEc:nat:nature:v:498:y:2013:i:7453:d:10.1038_nature12147
DOI: 10.1038/nature12147
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- John K. Barrows & Baicheng Lin & Colleen E. Quaas & George Fullbright & Elizabeth N. Wallace & David T. Long, 2022.
"BRD4 promotes resection and homology-directed repair of DNA double-strand breaks,"
Nature Communications, Nature, vol. 13(1), pages 1-10, December.
- Nathaniel G. Jones & Vincent Geoghegan & Gareth Moore & Juliana B. T. Carnielli & Katherine Newling & Félix Calderón & Raquel Gabarró & Julio Martín & Rab K. Prinjha & Inmaculada Rioja & Anthony J. Wi, 2022.
"Bromodomain factor 5 is an essential regulator of transcription in Leishmania,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Annkatrin Bressin & Olga Jasnovidova & Mirjam Arnold & Elisabeth Altendorfer & Filip Trajkovski & Thomas A. Kratz & Joanna E. Handzlik & Denes Hnisz & Andreas Mayer, 2023.
"High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:498:y:2013:i:7453:d:10.1038_nature12147. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.